Back to Search
Start Over
Enzastaurin, a targeted PKCBeta inhibitor, in relapsed or refractory DLBCL: a promising new strategy based on gene expression signature.
- Source :
-
Current oncology reports [Curr Oncol Rep] 2007 Sep; Vol. 9 (5), pp. 371; discussion 371. - Publication Year :
- 2007
Details
- Language :
- English
- ISSN :
- 1523-3790
- Volume :
- 9
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Current oncology reports
- Publication Type :
- Academic Journal
- Accession number :
- 17915376